Drug recall · October 21, 2015
TopCare LORATIDINE ORALLY DISINTEGRATING TABLETS recall
Why: Superpotent Drug: Out Of Specification (OOS) result for Assay.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
TopCare LORATIDINE ORALLY DISINTEGRATING TABLETS, , USP, 10 mg, packaged in a) Children's 10-count tablets per box (NDC 36800-528-69, UPC 0 3680010261 3); and b) 10-count tablets per box, (NDC 36800-527-69, UPC 0 3680008395 0); Distributed by Topco Associates, LLC, Elk Grove Village, IL 60007.
- Lots / codes
Batch Numbers: a) 2600127, Exp 2/29/2016; 2617892, Exp 5/31/2016; 2644265, 9/30/2016; 2625092, Exp, 6/30/2016; 2658140, Exp 11/30/2016. b) 2617892, Exp 5/31/2016; 2610783, 4/30/2016; 2644272, Exp 9/30/2016
- Quantity
- 53,688 boxes
- Company
- Ohm Laboratories, Inc., North Brunswick, NJ
- Distribution
- Nationwide.
- Initiated
- July 28, 2015 · Voluntary: Firm initiated
- Classified
- October 15, 2015
- Reported
- October 21, 2015
- Ended
- October 28, 2016
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.